Bradlee Heckmann

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Bradlee Heckmann and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Bradlee

Bradlee Heckmann

Co-founder & Chief Scientific Officer

Asha Therapeutics

Dr. Heckmann is a principal investigator at the USF Health Neuroscience Institute & Byrd Alzheimer’s Center and serves as the director of the Byrd Institute’s Center for Spatial Biology & Neuroimmunology with academic faculty appointments as an Assistant Professor in Molecular Medicine at the University of South Florida Morsani College of Medicine and as an Affiliate Professor in Medical Engineering at the University of South Florida College of Engineering. In addition to his academic appointments, Dr. Heckmann is a Scientific Co-founder and Chief Scientific Officer of Asha Therapeutics.

Talks About
#chemistry #management

Preferred Locations
#Northamerica

Speaking Engagements

6th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference

Paid

Our 6th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 22nd - 23rd June 2023, in Boston, would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss

22-23 June 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Bradlee Heckmann

Co-founder & Chief Scientific Officer

Speaking Engagements

6th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference